News

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary | PRLog

Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary. ACR Response Criteria - An Endpoint Used in Clinical Trials of Most of the Blockbuster Drugs for Rheumatoid Arthritis - PR11795760

Eisai Company Ltd s Cancer Drug Reverses

In what is seen as a major breakthrough in finding a cure for Alzheimer's, neuroscientists at Case Western Reserve University School of Medicine, Ohio,

Roche Holding's CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha

< p > Roche Holding Ltd. ( < a href='http://seekingalpha.com/symbol/rhhby.pk' title='Roche Hldg Ltd Spons' > RHHBY.PK < /a > ) < /p > < p > Q4 2011 Earnings Call < /p > < p > February 01, 2012 01:00 am ET < /p > < p > < strong > Executives < /strong > < /p > < p > Severin Schwan – Chief Executive

FDA Approves Subcutaneous Administration of VELCADE® In All Approved Indications {– Study met

CAMBRIDGE, Mass., January 23, 2012–Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE<sup>®</sup>

Call to scrap "misleading" GP antibiotic measures | 6minutes

One of the government’s key performance indicators for GPs – the prescribing of antibiotics for common colds – is highly misleading and should be scrapped, epidemiologists say.

Pancreas May ‘Taste’ Fructose, Hinting at Links to Diabetes - Health News - Health.com

By Serena GordonHealthDay ReporterMONDAY, Feb. 6 (HealthDay News) — New research shows that the pancreas has sweet-taste receptors — like those found on the tongue — that can “taste” fructose. Fructose is a common ingredient in many foods and beverages. Nutrition experts have warned that Americans

Clopidogrel with aspirin doesn’t prevent more small strokes, may increase risk of bleeding, death /

Clopidogrel with aspirin doesn’t prevent more small strokes, may increase risk of bleeding, death / American Heart Association AHA Newsroom, AHA News, heart news, heart health news, news releases, heart news releases, stroke news releases, stroke news, advocacy news, advocacy news releases, press

Boehringer Ingelheim, anti-hypertensi | Boehringer Ingelheim single combination of telmisartan and

Boehringer Ingelheim has released a new anti-hypertensive drug (TWYNSTA) containing a unique combination of telmisartan and amlodipine. Very often, hypertension sufferers take up to four drugs to reach an acceptable blood pressure (BP) more effectively. The single-pill combination drug is taken

Pfizer recalls 1m packets of birth control pills - FT.com

Pfizer, the world’s largest drug maker by revenues, has recalled 1m packets of birth control pills after finding that faulty packaging could potentially lead to unwanted pregnancies. “As a result of this packaging error, the daily regimen for these

Old Antidepressant Offers Promise In Treating Heart Failure - 01/05/2010

A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

Results 1-10 of 17,265
 

Refine by Topic:



Refine by Content Type:

  • Refined by: News  


Refine by Source:

50 Sources ...